SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

The iShares Silver Trust is seeing heightened activity as community members debate whether the asset is entering a fresh breakout phase fueled by industrial demand for chip production and potential supply chain constraints. Traders are closely tracking volatility in the silver-to-gold ratio and futures markets, with active discussions focused on whether the current momentum represents a sustainable bull run or a continuation of historical cycles of sharp, volatility-driven price swings.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna shares are surging as the company's early-stage research into an mRNA-based Hantavirus vaccine gains renewed attention following a cruise ship outbreak, sparking active discussion among community members debating whether this signals a new pandemic narrative or a short-term trading opportunity. Investors are closely watching for volatility expansion and potential short-squeeze activity as the community remains sharply divided between those betting on long-term vaccine demand and those skeptical of the headlines.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is trending as investors grapple with a significant disconnect between record-breaking quarterly financial performance and a suppressed stock price. The community is actively debating whether the current price action is driven by institutional manipulation, sector-wide consumer softness, or concerns regarding brand cannibalization and competitive pressure from rivals.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing an aggressive upward trend driven by an intense memory chip supercycle and heavy institutional accumulation as investors scramble to secure HBM and DRAM supply. The community is actively debating the sustainability of this parabolic move, with intense sentiment divided between those expecting a massive short-squeeze to new highs and those warning of a potential blow-off top.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as investors focus on the impending finalization of its acquisition of Northern Data and anticipation for upcoming earnings, which many in the community believe will validate a fundamental business pivot into AI and cloud infrastructure. While participants are actively debating the impact of a high short interest and the strategic backing of Tether, bullish sentiment remains anchored in the belief that these structural changes will drive a significant valuation re-rate.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle is experiencing significant volatility and community debate as investors weigh strong stablecoin transaction volume against regulatory uncertainty surrounding the CLARITY Act and recent platform security concerns. While traders remain sharply divided on the stock's direction, the conversation is heavily centered on upcoming earnings and how potential legislative clarity will impact its long-term infrastructure role in the crypto ecosystem.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is experiencing significant volatility and trading volume as investors react to a scheduled 1-for-20 reverse stock split. The community remains deeply divided, with some traders targeting a potential squeeze driven by a reduced float, while others warn of a persistent pattern of dilution and repeat splits that have historically eroded shareholder value.

Odysight.ai, Inc. engages in the development and manufacture of customized visual solutions for organizations across a variety of industries in the form of micro cameras and supplementary technologies. Its devices can used across the medical, aerospace, industrial, research, and defense industries. The company was founded on March 22, 2013 and is headquartered in Omer, Israel.

Odysight.ai Inc

Odysight.AI Inc

Odysight.AI is generating significant trading activity driven by a new Cooperative Research and Development Agreement with the U.S. Navy for AI-driven visual sensing technology. While some community members are optimistic about the potential for a momentum squeeze and defense sector growth, others are expressing skepticism regarding the company's long-term commercial execution and historical financial performance.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is currently trending as investors debate whether the recent volatility represents an attractive entry point or a sign of deeper structural issues following contract-related news and defense-sector rotation. The community is actively tracking the company's progress with its LOCUST laser technology and battlefield-proven drone systems, with many users focusing on the long-term potential of the autonomous defense sector despite current price turbulence.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following a positive pre-BLA meeting with the FDA, which confirmed a clear regulatory path toward a late-2026 BLA submission with potential priority review. Community discourse is heavily focused on the company's best-in-class label potential, strong cash position through 2027, and anticipation of upcoming Phase 3 trial data readouts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab

Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab Ginkgo Bioworks Reports First Quarter 2026 Financial Results...

Ginkgo Bioworks (NYSE:DNA) Stock Price Up 11.1% - What's Next?

Ginkgo Bioworks (NYSE:DNA) Trading Up 11.1% - What's Next...

Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation

Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation PR Newswire BOSTON, April 30, 2026 Presentation and Q&A session scheduled for post-market on Thursday, May 7, 2026BOSTON, April 30, 2026 /PRNewswire...

Ginkgo Bioworks (DNA) Projected to Post Quarterly Earnings on Tuesday

Ginkgo Bioworks (NYSE:DNA) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 5. (View Earnings Report at...

Ginkgo Bioworks (NYSE:DNA) Trading 6.9% Higher   - Here's What Happened

Ginkgo Bioworks (NYSE:DNA) Stock Price Up 6.9% - Still a Buy...

Short Interest in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Decreases By 23.2%

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Get Free Report) was the target of a significant decline in short interest in March. As of March 31st, there was short interest totaling 6,146,646 shares, a...

Ginkgo Bioworks (NYSE:DNA) Insider Sells $212,626.11 in Stock

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Get Free Report) insider Steven Coen sold 33,171 shares of Ginkgo Bioworks stock in a transaction on Monday, April 13th. The stock was sold at an average price of $6.41, for a total value of $212,626.11. Following the completion of the sale, the insider...

Steven Coen Sells 33,171 Shares of Ginkgo Bioworks (NYSE:DNA) Stock

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Get Free Report) insider Steven Coen sold 33,171 shares of the business's stock in a transaction that occurred on Monday, April 13th. The shares were sold...

Ginkgo Bioworks (NYSE:DNA) Insider Reshma Shetty Sells 124,727 Shares

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Get Free Report) insider Reshma Shetty sold 124,727 shares of the stock in a transaction on Friday, April 10th. The shares were sold at an average price of...

Ginkgo Bioworks Holdings, Inc. $DNA Shares Sold by Baillie Gifford & Co.

Baillie Gifford & Co. lessened its position in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 26.1% in the 4th quarter, according to its most recent filing with the Securities...

Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

DNA
Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest DNA News

DNAGinkgo Bioworks Holdings Inc - Ordinary Shares - Class A